Toward personalized therapy in AML: in vivo benefit of targeting aberrant epigenetics in MLL-PTD-associated AML.

ABSTRACT:

SUBMITTER: Bernot KM 

PROVIDER: S-EPMC3864138 | biostudies-literature | 2013 Dec

REPOSITORIES: biostudies-literature